Phase 1 Pharmacokinetic Trial of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048
Phase of Trial: Phase I
Latest Information Update: 06 May 2016
At a glance
- Drugs MK 2048/vicriviroc (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 03 May 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.